Prevalence and Impact of Polyvascular Disease in Patients With Acute Myocardial Infarction in the Contemporary Era of Percutaneous Coronary Intervention ― Insights From the Japan Acute Myocardial Infarction Registry (JAMIR) ―
Circulation Journal · 2024
DOI: 10.1253/circj.cj-23-0477 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation Journal, 2024. Verfasst von Riku Arai und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Nihon University School of Medicine. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Registries, Myocardial Infarction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: This post hoc subanalysis aimed to investigate the impact of polyvascular disease (PolyVD) in patients with acute myocardial infarction (AMI) in the contemporary era of percutaneous coronary intervention (PCI). METHODS AND RESULTS: The Japan Acute Myocardial Infarction Registry (JAMIR), a multicenter prospective registry, enrolled 3,411 patients with AMI between December 2015 and May 2017. Patients were classified according to complications of a prior stroke and/or peripheral artery disease into an AMI-only group (involvement of 1 vascular bed [1-bed group]; n=2,980), PolyVD with one of the complications (2-bed group; n=383), and PolyVD with both complications (3-bed group; n=48). The primary endpoint was all-cause death. Secondary endpoints were major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and major bleeding. In the 1-, 2-, and 3-bed groups, the cumulative incidence of all-cause death was 6.8%, 17.5%, and 23.7%, respectively (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Nihon University School of Medicine.
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.
- Department of Cardiology, Miyazaki Medical Association Hospital.
- Department of Internal Medicine, Sakurajyuji Yatsushiro Rehabilitation Hospital.
- Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center.
- Department of Public Health and Health Policy, Graduate School of Medicine, The University of Tokyo.
Zitieren
APA
Arai, R., Okumura, Y., Murata, N., Fukamachi, D., Honda, S., Nishihira, K., Kojima, S., Takegami, M., Asaumi, Y., Yamashita, J., Saji, M., Hibi, K., Takahashi, J., Sakata, Y., Takayama, M., Sumiyoshi, T., Ogawa, H., Kimura, K., Yasuda, S., & JAMIR Investigators (2024). Prevalence and Impact of Polyvascular Disease in Patients With Acute Myocardial Infarction in the Contemporary Era of Percutaneous Coronary Intervention ― Insights From the Japan Acute Myocardial Infarction Registry (JAMIR) ―. Circulation Journal. https://doi.org/10.1253/circj.cj-23-0477
Vancouver
Arai R, Okumura Y, Murata N, Fukamachi D, Honda S, Nishihira K, et al. Prevalence and Impact of Polyvascular Disease in Patients With Acute Myocardial Infarction in the Contemporary Era of Percutaneous Coronary Intervention ― Insights From the Japan Acute Myocardial Infarction Registry (JAMIR) ―. Circulation Journal. 2024. doi:10.1253/circj.cj-23-0477
BibTeX
@article{Arai2024,
author = {Arai, Riku and Okumura, Yasuo and Murata, Nobuhiro and Fukamachi, Daisuke and Honda, Satoshi and Nishihira, Kensaku and Kojima, Sunao and Takegami, Misa and Asaumi, Yasuhide and Yamashita, Jun and Saji, Mike and Hibi, Kiyoshi and Takahashi, Jun and Sakata, Yasuhiko and Takayama, Morimasa and Sumiyoshi, Tetsuya and Ogawa, Hisao and Kimura, Kazuo and Yasuda, Satoshi and JAMIR Investigators, JAMIR Investigators},
title = {Prevalence and Impact of Polyvascular Disease in Patients With Acute Myocardial Infarction in the Contemporary Era of Percutaneous Coronary Intervention ― Insights From the Japan Acute Myocardial Infarction Registry (JAMIR) ―},
journal = {Circulation Journal},
year = {2024},
doi = {10.1253/circj.cj-23-0477}
}
EUVIMED